{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:54:29Z","timestamp":1791971669416,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":235,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Intensive Care"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.aicoj.2026.100139","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:04:07Z","timestamp":1787670247000},"page":"100139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Early de-escalation of antifungal treatment in critically ill immunocompromised patients with proven or probable invasive candidiasis: A retrospective multicentre study"],"prefix":"10.1016","volume":"16","author":[{"given":"Karim","family":"Jaffal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constance","family":"Bayon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Kreitmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Rouz\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Labruyere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabelle","family":"Stoclin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Reignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Brunin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Dartevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boualem","family":"Sendid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Labreuche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Nseir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aicoj.2026.100139_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.blre.2015.04.002","article-title":"Managing critically ill hematology patients: Time to think differently","volume":"29","author":"Azoulay","year":"2015","journal-title":"Blood Rev"},{"key":"10.1016\/j.aicoj.2026.100139_bib0010","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1007\/s00134-017-4884-z","article-title":"The Intensive Care Medicine research agenda on critically ill oncology and hematology patients","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0015","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00134-023-07295-2","article-title":"ICU-acquired infections in immunocompromised patients","volume":"50","author":"Kreitmann","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s13054-019-2497-3","article-title":"Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project","volume":"23","author":"Bassetti","year":"2019","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.aicoj.2026.100139_bib0025","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00134-020-06240-x","article-title":"Invasive candidiasis in critical care: challenges and future directions","volume":"46","author":"Logan","year":"2020","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0030","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1007\/s00134-024-07683-2","article-title":"Invasive fungal infections in non-neutropenic patients","volume":"50","author":"Kreitmann","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0035","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.cmi.2019.04.024","article-title":"Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis","volume":"25","author":"Koehler","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.aicoj.2026.100139_bib0040","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00134-014-3310-z","article-title":"A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality","volume":"40","author":"Bassetti","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0045","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/cid\/cis305","article-title":"Septic shock attributed to Candida infection: importance of empiric therapy and source control","volume":"54","author":"Kollef","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0050","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0055","doi-asserted-by":"crossref","first-page":"e280","DOI":"10.1016\/S1473-3099(24)00749-7","article-title":"Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM","volume":"25","author":"Cornely","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.7326\/0003-4819-149-2-200807150-00004","article-title":"Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial","volume":"149","author":"Schuster","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/jama.2016.14655","article-title":"Empirical micafungin treatment and survival without invasive fungal infection in adults with ICU-acquired sepsis, Candida colonization, and multiple organ failure: the EMPIRICUS randomized clinical trial","volume":"316","author":"Timsit","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2026.100139_bib0070","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1097\/CCM.0b013e318236f297","article-title":"Systemic antifungal therapy in critically ill patients without invasive fungal infection","volume":"40","author":"Azoulay","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0075","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00134-017-4932-8","article-title":"Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial","volume":"43","author":"Rouz\u00e9","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0080","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13054-020-03265-y","article-title":"(1,3)-\u03b2-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trial","volume":"24","author":"De Pascale","year":"2020","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.aicoj.2026.100139_bib0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients","volume":"18 Suppl 7","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.aicoj.2026.100139_bib0090","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofab250","article-title":"Early Stepdown from echinocandin to fluconazole treatment in candidemia: a post hoc analysis of three cohort studies","volume":"8","author":"Moreno-Garc\u00eda","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0095","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2334-14-97","article-title":"Evaluation of an early step-down strategy from intravenous anidulafungin to oral azole therapy for the treatment of candidemia and other forms of invasive candidiasis: results from an open-label trial","volume":"14","author":"Vazquez","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13613-018-0392-8","article-title":"De-escalation of antifungal treatment in critically ill patients with suspected invasive Candida infection: incidence, associated factors, and safety","volume":"8","author":"Jaffal","year":"2018","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.aicoj.2026.100139_bib0105","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00134-015-4053-1","article-title":"Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data","volume":"41","author":"Bailly","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0110","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cmi.2019.03.028","article-title":"Resistance of Candida to azoles and echinocandins worldwide","volume":"25","author":"Pristov","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.aicoj.2026.100139_bib0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5495\/wjcid.v5.i4.55","article-title":"How could we reduce antifungal use in the intensive care unit?","volume":"5","author":"Rouz\u00e9","year":"2015","journal-title":"World J Clin Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0120","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00134-022-06954-0","article-title":"Relationship between immunosuppression and intensive care unit-acquired colonization and infection related to multidrug-resistant bacteria: a prospective multicenter cohort study","volume":"49","author":"Kreitmann","year":"2023","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0125","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2015.12402","article-title":"Effect of noninvasive ventilation vs oxygen therapy on mortality amongst immunocompromised patients with acute respiratory failure: a randomized clinical trial","volume":"314","author":"Lemiale","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.aicoj.2026.100139_bib0130","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0135","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.aicoj.2026.100139_bib0140","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00134-019-05599-w","article-title":"ESICM\/ESCMID task force on practical management of invasive candidiasis in critically ill patients","volume":"45","author":"Martin-Loeches","year":"2019","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1097\/01.CCM.0000202208.37364.7D","article-title":"A bedside scoring system (\u201cCandida score\u201d) for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization","volume":"34","author":"Le\u00f3n","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.aicoj.2026.100139_bib0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.aicoj.2026.100139_bib0155","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.aicoj.2026.100139_bib0160","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/10543406.2023.2275759","article-title":"Adjusted win ratio using the inverse probability of treatment weighting","volume":"35","author":"Wang","year":"2025","journal-title":"J Biopharm Stat"},{"key":"10.1016\/j.aicoj.2026.100139_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103300","article-title":"Advocating for the recognition of underlying immunosuppression in critical illness","volume":"85","author":"Martin-Loeches","year":"2025","journal-title":"eClinicalMedicine"}],"container-title":["Annals of Intensive Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582026001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2110582026001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T09:33:27Z","timestamp":1791970407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2110582026001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":33,"alternative-id":["S2110582026001743"],"URL":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100139","relation":{},"ISSN":["2110-5820"],"issn-type":[{"value":"2110-5820","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early de-escalation of antifungal treatment in critically ill immunocompromised patients with proven or probable invasive candidiasis: A retrospective multicentre study","name":"articletitle","label":"Article Title"},{"value":"Annals of Intensive Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aicoj.2026.100139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 de R\u00e9animation de Langue Fran\u00e7aise (French Intensive Care Society).","name":"copyright","label":"Copyright"}],"article-number":"100139"}}